Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03637491
Title A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer

Advanced Solid Tumor

lung non-small cell carcinoma

pancreatic ductal adenocarcinoma


Avelumab + Binimetinib + Talazoparib

Avelumab + Binimetinib

Age Groups: senior | adult
Covered Countries USA | BEL

Additional content available in CKB BOOST